Number of women requiring further treatment such as surgery, drugs, mechanical devices (relapse) ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of women reporting incontinence at 1 year or more after treatment (subjective) ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of women requiring further treatment such as surgery, drugs, mechanical devices (relapse) ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of women requiring further treatment such as surgery, drugs, mechanical devices (relapse) ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of women reporting incontinence at 1 year or more after treatment (subjective) ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Overall QoL change score ‐ up to 12 weeks' · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall physical function change score ‐ 6 months' · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall role function change score ‐ up to 12 weeks' · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall role function · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall social function change score ‐ up to 12 weeks' · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall social function · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall QoL · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall anxiety · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall anxiety · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall depression · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall depression · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall fatigue change score ‐ up to 12 weeks' · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall fatigue · people who are undergoing active treatment for cancer
1 finding from 1 review
Intervention not reported
Overall physical function change score ‐ up to 12 weeks' · people who are undergoing active treatment for cancer
1 finding from 1 review
Process outcome, Practitioner Impact 1. Polypharmacy at · patients with schizophrenia or related psychoses
It is very uncertain whether active education + Support for implementation changes process outcome, Practitioner Impact 1. Polypharmacy at compared with routine care or Passive dissemination (very low certainty).
1 finding from 1 review